Patient-Reported Outcome Measures in Symptomatic, Non–Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review
Patient-Reported Outcome Measures in Symptomatic, Non–Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review
复制标题
有症状、无肢体威胁的外周动脉疾病患者报告的结果测量：最先进的综述
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
K. Smolderen
中科院分区：
文献类型：
--
作者：
Jennifer A. Rymer;Dennis I. Narcisse;Michael Cosiano;John Tanaka;Mary M. McDermott;Diane Treat;Michael S. Conte;Brandi Tuttle;Manesh R. Patel;K. Smolderen
文本中提供了补充数字内容。患者报告的结果测量（PROM）是患者直接报告的健康结果，可用于衡量疾病和治疗对患者感知健康的影响。本综述总结了有关 PROM 在有症状、非肢体威胁性外周动脉疾病患者中验证的最新证据。我们进行了文献检索，以确定无肢体威胁性缺血的症状性外周动脉疾病的研究，其中包括 PROM，并且样本量≥25。使用经典测试理论框架并根据它们是否满足 (1) 内容有效性的定义标准，对 PROM 进行了连续验证。 (2) 心理测量验证； (3)进一步扩大验证证据基础。在确定的 2198 篇文章中，157 篇 (7.1%) 符合纳入标准。对 24 名有症状的外周动脉疾病患者的 PROM 进行了审查。在疾病特异性 PROM 中，15 个 PROM 中的 8 个具有出色的可靠性（通过 Cronbach α ≥0.80 衡量）。根据既定的 PROM 反应性标准，15 个疾病特异性 PROM 中有 6 个表现出对变化的出色敏感性。其中，疾病特异性外周动脉问卷、血管生活质量问卷和步行障碍问卷均符合连续体每个阶段的验证标准。对于通用（非疾病特异性）PROM，欧洲生活质量 5 维和 SF-36 拥有最广泛的验证证据。鉴于验证程度的不同以及措施的潜在补充性质，本次审查的证据可以为选择符合科学和临床目标的 PROM 提供信息。
Supplemental Digital Content is available in the text. Patient-reported outcome measures (PROMs) are health outcomes directly reported by the patient that can be used to measure the effect of disease and treatments on patient perceived well-being. This review summarizes current evidence regarding the validation of PROMs in people with symptomatic, nonlimb-threatening peripheral artery disease. A literature search was conducted to identify studies of symptomatic peripheral artery disease without limb-threatening ischemia that included PROMs and had sample sizes ≥25. PROMs were summarized along a continuum of validation using classical test theory framework and according to whether they fulfilled defined criteria for (1) content validity; (2) psychometric validation; and (3) further validation evidence base expansion. Of 2198 articles identified, 157 (7.1%) met inclusion criteria. Twenty-four PROMs in patients with symptomatic peripheral artery disease were reviewed. Among disease-specific PROMs, 8 of 15 had excellent reliability as measured by a Cronbach alpha ≥0.80. Based on established criteria for PROM responsiveness, 6 of 15 disease-specific PROMs demonstrated excellent sensitivity to change. Of these, the disease-specific peripheral artery questionnaire, vascular quality of life questionnaire, and walking impairment questionnaire met criteria for validation at each stage of the continuum. For generic (nondisease specific) PROMs, the European Quality of Life 5-Dimension and SF-36 had the most extensive evidence of validation. Evidence from this review can inform selection of PROMs aligned with scientific and clinical goals, given the variable degree of validation and potential complementary nature of the measures.
登录
查看更多内容
影响因子：
24
作者：
Jain A;Liu K;Ferrucci L;Criqui MH;Tian L;Guralnik JM;Tao H;McDermott MM
通讯作者：
McDermott MM
影响因子：
120.7
作者：
McDermott, Mary M.;Spring, Bonnie;Rejeski, W. Jack
通讯作者：
Rejeski, W. Jack
影响因子：
4.3
作者：
Izquierdo-Porrera, AM;Gardner, AW;Katzel, LI
通讯作者：
Katzel, LI
影响因子：
120.7
作者：
McDermott, Mary M.;Ades, Philip;Guralnik, Jack M.;Dyer, Alan;Ferrucci, Luigi;Liu, Kiang;Nelson, Miriam;Lloyd-Jones, Donald;Van Horn, Linda;Garside, Daniel;Kibbe, Melina;Domanchuk, Kathryn;Stein, James H.;Liao, Yihua;Tao, Huimin;Green, David;Pearce, William H.;Schneider, Joseph R.;McPherson, David;Laing, Susan T.;McCarthy, Walter J.;Shroff, Adhir;Criqui, Michael H.
通讯作者：
Criqui, Michael H.
外周动脉疾病功能损伤的医疗管理：综述。
影响因子：
9.1
作者：
McDermott,MaryM
通讯作者：
McDermott,MaryM